Страна: Европейски съюз
Език: български
Източник: EMA (European Medicines Agency)
Istradefylline
Kyowa Kirin Holdings B.V.
N04
istradefylline
Антипаркинсонови лекарства
Паркинсонова болест
Istradefylline is indicated in adults as an adjunctive treatment to levodopa based regimens in patients with Parkinson’s disease (PD) experiencing “OFF” time.
Отказана